Carmot Australia First Pty Ltd clinical trials
Acquired by Hoffmann-La Roche
The registry lists 1 studies whose lead sponsor is Carmot Australia First Pty Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 28, 2025.
- 1study on the registry
- 0open to participants now
What it is testing
The drugs Carmot Australia First Pty Ltd’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Over the years
- 123
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Carmot Australia First Pty Ltd1 study
Something wrong with this grouping? Tell us on the Hoffmann-La Roche page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Hoffmann-La Roche studies →
- Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes MellitusCompletedNCT05814107Phase 1
Sponsor listed in the registry: Carmot Australia First Pty Ltd · Carmot Australia First Pty Ltd — acquired company within the Hoffmann-La Roche group